Steven Come is an Oncology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 262 publications with 9,923 citations (h-index 48); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Boston, MA 022155400
Telephone
617-667-4599Registry record last updated 8 Jul 2007.
Clinical trials
- The Young Women's Breast Cancer Study
Sponsor: Dana-Farber Cancer Institute
- Efficacy and Safety of 500mg of Fulvestrant
Sponsor: Beth Israel Deaconess Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
73%Aromatase Inhibitor73%Anastrozole48%Letrozole40%Exemestane12%Part D<11 patientsNervous system
27%Benzodiazepine13.5%Lorazepam100%Part D<11 patientsOpioid Agonist13.5%Oxycodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1985–2009 per NIH RePORTER. The latest:
- Biology and treatment of Brca1-Associated and Sporadic Basal-like Cancers
Dana-Farber Cancer Inst
FY2009$179,055P50CA089393 - Biology and treatment of Brca1-Associated and Sporadic Basal-like Cancers
Dana-Farber Cancer Inst
FY2008$104,882P50CA089393 - CIS DIAMMINEDICHOLRO PLATINUM FOR REGIONALLY CONFINED MALIGNANCY
Beth Israel Deaconess Medical Center
FY1985M01RR001032
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”